Chengjun Zhu

机构：Inner Mongolia University, Jiangsu Province Hospital, Henan Polytechnic University, Nanjing Medical University · ORCID：0000-0002-2867-562X

发表论文 71 篇 · 总被引 1126 次 · h-index 14

代表论文

• Real-world application of disitamab vedotin (RC48-ADC) in patients with breast cancer with different HER2 expression levels: efficacy and safety analysis (2024 · The Oncologist · 被引 10)
• Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies (2024 · Journal of Advanced Research · 被引 9)
• Enrichment and Detection of HER2-Expressing Extracellular Vesicles Based on DNA Tetrahedral Nanostructures: A New Strategy for Liquid Biopsy in Breast Cancer (2025 · Analytical Chemistry · 被引 8)
• On forecast stability (2025 · International Journal of Forecasting · 被引 8)
• Improved reversibility and kinetics of oxygen redox reaction in Na2Mn3O7 by dual-site regulation strategy (2025 · Journal of Power Sources · 被引 5)
• Effect of temperature on damage mechanism and fracture behavior of LiH ceramic under 3-point bending at different loading rates (2024 · Ceramics International · 被引 5)